ClinicalTrialsFinder

Severe Proteinuria Due to Idiopathic Membranous Nephropathy Clinical Trials in Aarhus

1 recruitingAarhus, Denmark

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria

Nephrotic Syndrome Due to Idiopathic Membranous NephropathySevere Proteinuria Due to Idiopathic Membranous Nephropathy
SynAct Pharma Aps23 enrolled1 locationNCT04456816